Evidence map›Paper›PMID 39480534›Full record

ArticleEuropean radiology2025

Performance of breast MRI for high-risk screening during lactation.

Noam Nissan, Jill Gluskin, Rosa Elena Ochoa-Albiztegui, Hila Fruchtman-Brot, Janice S Sung, Maxine S Jochelson

Abstract read
PubMed Publisher
In one paragraph

Article in European radiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Noam NissanDepartment of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
Jill GluskinDepartment of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
Rosa Elena Ochoa-AlbizteguiDepartment of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
Hila Fruchtman-BrotDepartment of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
Janice S SungDepartment of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
Maxine S JochelsonDepartment of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA. maxine.jochelson@radnet.com.ORCID http://orcid.org/0000-0002-4012-2470

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

objectivesTo assess the diagnostic performance of breast MRI during lactation in the setting of high-risk breast cancer screening. MATERIALS AND

methodsScreening breast MRIs performed between April 2008 and March 2024 were retrospectively reviewed. Background parenchymal enhancement (BPE) grade was compared between lactating patients and patients who recently stopped lactating using the Mann-Whitney test. Breast Imaging Reporting and Data System (BI-RADS) scores prevalence rates were compared between lactating patients and controls encompassing young non-lactating patients using the Chi-square test. Diagnostic performance was calculated for patients with a biopsy reference or a 1-year radiologic follow-up.

resultsOne-hundred forty-two screening breast MRIs were performed in lactating patients (n = 104, median age, 36.0 ± 6.0 years). Marked BPE appeared in 82% of cases (116/142), with a higher BPE grade in exams performed during lactation as compared with those performed in patients who had recently ceased lactating (p < 0.001). Screening MRIs performed during lactation had a higher rate of BI-RADS 3 scores (40/142, 28% vs. 683/8922, 7%, p < 0.001) and a lower rate of BI-RADS 1/2 scores (88/142, 62% vs. 7549/8922, 84.6%, p = 0.002) compared with those performed in controls (n = 8922). One pregnancy-associated breast cancer was detected, and one interval-cancer occurred. All MRI-guided biopsies were negative (n = 13). Screening breast MRI during lactation had 50% sensitivity (1/2), 60% specificity (72/120), 2.0% positive predictive value (1/49), and 98.6% negative predictive value (71/82).

conclusionThe efficacy of breast MRI for high-risk screening during lactation is limited by prominent BPE, leading to an increased rate of BI-RADS 3 categorization and diminished overall specificity. KEY POINTS: Question Studies on breast MRI during lactation were solely focused on studies conducted in patients with known cancer but not in the screening setting. Findings Screening breast MRI during lactation usually results in marked background parenchymal enhancement, negatively impacting its diagnostic performance. Clinical relevance Despite the lower performance, and amidst the significant risk of pregnancy-associated breast cancer, this screening approach remains relevant for lactating patients with high-risk profiles, such as BReast Cancer (BRCA) carriers. Radiologists should be familiar with the normal appearance of breast MRI during lactation.

Indexed as

Breast NeoplasmsEarly Detection of CancerLactationMagnetic Resonance ImagingAdultBreastFemaleHumansMiddle AgedRetrospective StudiesSensitivity and SpecificityBreast neoplasmsMagnetic resonance imagingPregnancy

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.